Posts Tagged ‘OHSU Knight Cancer Institute’

W. M. Keck Foundation to support new microscopy collaboration at OHSU

The OHSU Center for Spatial Systems Biomedicine (OCSSB), a multidisciplinary center within the OHSU Knight Cancer Institute and School of Medicine, has been awarded $1 million by the W. M. Keck Foundation to support the world’s first microscope that integrates both light and electron microscope techniques. This state-of-the-art technology, being developed in collaboration with Hillsboro-based FEI, allows researchers to associate cell behavior to precise points in the cellular architecture. Researchers from around the globe, including OHSU, … Read More

Tomasz Beer, M.D., to join Dream Team for prostate cancer research

OHSU researcher and Knight Cancer Institute Deputy Director Tomasz Beer, M.D., has been selected to participate in a prestigious, six-person Dream Team to fight advanced-stage prostate cancer. Funding for this collaborative initiative is provided by Stand Up to Cancer, the Prostate Cancer Foundation, and the American Association for Cancer Research. Dr. Beer will be working with researchers from four University of California campuses–San Francisco, Los Angeles, Santa Crus, and Davis–as well as the University of … Read More

Mentor a Murdock Scholar next summer

If you’re a faculty member who is part of the Knight Cancer Institute or OHSU Heart Research Center, consider mentoring an undergraduate biology student through the Murdock Undergraduate Collaborative Research Program next summer. Mentors work with a Murdock Scholar for ten weeks during the summer on a project and continue to assist the scholar throughout the following year to prepare a final thesis and give a presentation at a special session of the Oregon Academy … Read More

Cell & Developmental Biology to host Craig T. Jordan, Ph.D., Sept. 25

The Knight Cancer Institute Seminar Series continues with a presentation on the “Characterization and Targeting of Leukemia Stem Cells” by Craig T. Jordan, PhD. Dr. Jordan is a Phillip and Marilyn Wehreim Professor of Medicine from the Division of Hematology/Oncology at the James P. Wilmot Cancer Center and Professor of Biomedical Genetics and the University of Rochester School of Medicine. The presentation will take place in the OHSU Hospital’s 8th floor conference room, 8B60, at 4 … Read More

Charles D. Blanke, M.D., chair-elect of SWOG, joins OHSU

OHSU’s Knight Cancer Institute has recruited Charles D. Blanke, M.D., chair-elect of SWOG, one of the largest National Cancer Institute-funded clinical trial networks. As leader of SWOG, Dr. Blanke will oversee $40 million in research funding annually. The Knight Cancer Institute is expected to benefit by receiving $20 to $25 million and increased access to SWOG clinical trials. Dr. Blanke’s recruitment supports the Knight Cancer Institute’s mission of being a leader in personalized cancer medicine. … Read More

Updated: V Scholars in cancer research, internal applications due June 15

Updated 6/7/12: The criteria for this funding opportunity have changed to include the acceptance of proposals for translational research projects. Therefore, we are extending the internal deadline to next Friday, June 15. ————————————————— OHSU has been invited by the V Foundation to apply for their V Scholar Program, an opportunity for young, talented cancer researchers to gain support in their development into successful, independent investigators. The two-year, $200,000 grant will provide funds directly to young scientists … Read More

OHSU to host international symposium for cancer and stem cell research, June 5

The Macy Easom Cancer Research Foundation has partnered with world-class cancer and stem cell physician-scientists to bring together some of the best minds in the field in hopes of stimulating hepatoblastoma and other pediatric cancer research. OHSU is proud to host the Macy Easom Memorial Lectureship, which will be held in the OHSU Hospital’s eighth-floor auditorium on Tuesday, June 5th at 4 p.m. Dr. Stefano Cairo, Ph.D., a human geneticist at XenTech in Paris, France has … Read More

Knight study on multiple myeloma supports new standard of treatment

A new study, published in the New England Journal of Medicine, found that 63 percent of multiple myeloma patients have a reduced risk of disease progression or death if treated with lenalidomide (Revlimid®) following a stem cell transplant. The study was co-authored by Richard Mariarz, MD, medical director of the Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies at the Knight Cancer Institute. Read the OHSU News Release to learn more.

Nobel Laureate Elizabeth Blackburn, Ph.D., on campus April 17

The Knight Cancer Institute invites you to attend its latest talk featuring distinguished scientist and Nobel Laureate Elizabeth Blackburn, Ph.D., a Morris Herztein Endowed Professor in Biology and Physiology University of California, San Francisco, Department of Biochemistry and Biophysics. Dr. Blackburn will be discussing “Telomeres and their maintenance machinery: Ramifications for cells and organisms.” This seminar will take place at 4:00 p.m. on Tuesday, April 17 in the Old Library Auditorium. About Dr. Blackburn Dr. Blackburn is … Read More

Reminder: BioMedicine in 4D conference at OHSU, March 21-23

The 2012 BioMedicine in 4D Symposium, hosted by OHSU’s Center for Spatial Systems Biomedicine, will be held March 21 – 23 in the OHSU Old Library. Keynote speakers include Brian Druker, M.D., on March 22, and Stephen Quake, D.Phil, on March 23. Sessions will explore integration of -omics with new and developing microscopy techniques, expanded role of modeling, and translation of the new approaches into therapies. The Center for Spatial Systems Biomedicine brings exciting initiatives … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives